Evidence map›Paper›PMID 26842718›Full record

Observational studyNeurocritical care2016

Hypernatremia at Hospital Discharge and Out of Hospital Mortality Following Primary Intracerebral Hemorrhage.

Torrey Boland, Galen V Henderson, Fiona K Gibbons, H Bart Brouwers, Steven M Greenberg, Miriam Raffeld, Christina E Kourkoulis, Jonathan Rosand, Kenneth B Christopher

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Neurocritical care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Torrey BolandDepartment of Neurology, Rush University Medical Center, Chicago, IL, USA.
Galen V HendersonDepartment of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
Fiona K GibbonsDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
H Bart BrouwersDepartment of Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
Steven M GreenbergDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Miriam RaffeldDepartment of Neurology and Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA.
Christina E KourkoulisDepartment of Neurology and Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA.
Jonathan RosandDepartment of Neurology and Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA.
Kenneth B ChristopherThe Nathan E. Hellman Memorial Laboratory, Renal Division, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, MRB 418, Boston, MA, 02115, USA. kbchristopher@partners.org.
Massachusetts General Hospital · USBrigham and Women's Hospital · USRush University Medical Center · USUniversity Medical Center Utrecht · NL

Funding

Gene Discovery for Warfarin-Related Intracerebral HemorrhageR01NS059727 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROSAND, JONATHAN · 2008 to 2012
$4.2M
NINDS NIH HHS R01 NS059727
6 · The paper itself

Abstract

background and purposeIn patients with intracerebral hemorrhage (ICH), it is not clear if hypernatremia is merely a marker of disease severity or if elevated sodium levels are harmful. We hypothesized that hypernatremia at hospital discharge in primary ICH patients would be associated with increased mortality following discharge.

methodsWe performed a two-center observational study of critically ill ICH patients in Boston. We studied 5100 patients, age ≥18 years, who were diagnosed with ICH (ICD-9 code 431), received medical or surgical critical care between 1997 and 2011 and survived hospitalization. The exposure of interest was serum sodium within 24 h of hospital discharge, categorized as Na ≤ 145 mmol/L and Na > 145 mmol/L. The primary outcome was 30-day post-discharge mortality. Odds ratios were estimated by logistic regression models adjusted for age, race, gender, Deyo-Charlson Index, patient type (medical versus surgical) and sepsis.

resultsIn ICH patients who received critical care and survived hospitalization, the serum sodium at discharge was a predictor of post-discharge mortality. Patients with a discharge Na > 145 mmol/L have an OR for mortality in the 30 days following hospital discharge of 1.82 (95 %CI 1.38-2.38; P < 0.001) and an adjusted OR of 1.87 (95 %CI 1.40-2.48; P < 0.001) both relative to patients with a discharge Na ≤ 145 mmol/L. The adjusted model showed good discrimination AUC 0.77 (95 %CI 0.74-0.79) and calibration (Hosmer-Lemeshow χ (2) P = 0.68).

conclusionsIn critically ill ICH patients who survive hospitalization, hypernatremia at the time of discharge is a robust predictor of post-discharge mortality.

Indexed as

Outcome Assessment, Health CareAgedAged, 80 and overCerebral HemorrhageCritical CareFemaleHumansHypernatremiaMaleMiddle AgedPatient DischargeCritical careHypernatremiaIntensive careIntracerebral hemorrhageMortalitySodium

Identifiers

PMID26842718
OpenAlexW2269483281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.